Clinical Trial Detail

NCT ID NCT02463994
Title A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Michigan Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: adult

Additional content available in CKB BOOST